Delivery Order SPE2DB20D2014-SPE2DB25FC68Q
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors with a ceiling value of $1,434.02 and an ultimate completion date of June 2, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The product will be delivered to the vendor's...
- AmerisourceBergen Drug Corp was awarded a $2,451.26 delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injector (0.5 mL). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive award outside of any set-aside program. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- On July 29, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a $2,905.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL pen injectors. This is a non-set-aside contract awarded through open competition, with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a $13,635.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The contract, which carries an ultimate completion date of July 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,595.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Imitrex 4 mg/0.5 mL pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,869.17 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a prescription medication used to treat migraine headaches, and this...
- The Defense Logistics Agency has awarded a $2,288.07 delivery order to AmerisourceBergen Drug Corp for IMITREX 4 mg/0.5 mL pen injectors, with an ultimate completion date of May 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and the company's corporate office is designated as both the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC68QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's federal contract awards with the DLA demonstrate consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains. This Imitrex delivery order supports the Defense Health Agency and other military healthcare systems' immediate pharmaceutical supply needs, reflecting the company's role as a primary vendor for neurological treatments and other specialized medications within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/7/25 |